Carmignac Gestion’s Terns Pharmaceuticals TERN Stock Holding History

Carmignac Gestion’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-53,541	Closed	-$2.82M	–	129
2026 Q1	$2.82M	Buy	+53,541	New	+$2.2M	0.04%	75

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carmignac Gestion's TERN Position: Q2 2026 in Review

Carmignac Gestion sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 53,541 shares — an estimated $2.82M sold.

Carmignac Gestion first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $2.82M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Carmignac Gestion reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Carmignac Gestion sold 53,541 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.82M.
Carmignac Gestion first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Carmignac Gestion's Terns Pharmaceuticals position peaked at $2.82M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.